Incisional Negative Pressure Therapy to Prevent Animal Induced Wound Infection
Launched by PEKING UNIVERSITY FIRST HOSPITAL · Aug 15, 2024
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new treatment method called incisional negative pressure wound therapy (iNPWT) to see if it can help prevent infections in deep wounds caused by animal bites or scratches. Each year, millions of people are hurt by animals, which can lead to serious infections. In this study, researchers will compare iNPWT, which uses a gentle suction to help wounds heal and stay clean, with regular gauze dressings on patients who have had severe animal injuries. The goal is to find out if iNPWT can lower the chances of infection and speed up healing for these types of wounds.
To participate in this study, you would need to have a deep wound from an animal bite that requires stitches and is at least 2 centimeters long. The study is open to all adults aged 18 and older who meet these criteria. Unfortunately, if you've had an infection in your wound or waited more than 8 hours to get treated, you wouldn't be eligible to join. Participants will receive either the iNPWT treatment or standard gauze and will be monitored to see how well their wounds heal and if there are any infections. This trial aims to provide valuable information that could improve how we treat animal bite wounds in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Limds injuries caused by animals, first or second animal injury to Grade III exposed patients, with deep wounds reaching the fat layer, tendons, and even penetrating injuries.
- • Patients with wounds\>2cm and severe injuries that even require surgical treatment.
- Exclusion Criteria:
- • Missing or incomplete follow-up data within 30 days.
- • Patients who have been infected with wounds or have been injured for more than 8 hours before seeking medical attention.
- • Acupuncture like wound (\<2mm).
- • Patients with whole skin detachment.
About Peking University First Hospital
Peking University First Hospital is a leading medical institution in China, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its extensive expertise in various medical fields to conduct rigorous studies aimed at improving patient outcomes and contributing to global medical knowledge. With a multidisciplinary team of skilled researchers and clinicians, Peking University First Hospital is dedicated to the ethical conduct of clinical research, ensuring the highest standards of safety and efficacy in its trials. The institution plays a vital role in translating scientific discoveries into effective treatments, thereby enhancing the quality of care for patients both locally and worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Trial Officials
Shi Jiping, Master
Principal Investigator
Peking University First Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported